Clinical and Chemical Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420961202. doi: 10.1177/2058738420961202.
Despite the link between HCV and malignant lymphoproliferative disorders has been established, the association between occult hepatitis C virus infection and malignant lymphoproliferative disorders remains obscure. The present study intended to identify the possible association between occult HCV infection and malignant lymphoproliferative disorders. Newly diagnosed patients with LPDs were screened for the presence of HCV-RNA in both plasma and PBMCs. PBMCs of the subjects were also, examined by transmission and immuno-electron microscopy. LPD patients showed a high percentage of HCV infection (71.9%): OCI-HCV (37.5%) and HCV (34.38%). Meanwhile, 28.13% of LPD patients did not show any evidence of HCV infection. Ultrastructural examination of PBMCs revealed the presence of intracytoplasmic vacuoles enclosing viral like particles, which were less prominent in occult HCV patients. The possibility of occult HCV should be considered in patients with LPDs which can be helpful in the management of the treatment protocol in order to set up a balance between the control of the tumor progression and minimizing post chemotherapy complications related to HCV infection.
尽管已经确定 HCV 与恶性淋巴增生性疾病之间存在关联,但隐匿性丙型肝炎病毒感染与恶性淋巴增生性疾病之间的关联仍不清楚。本研究旨在确定隐匿性 HCV 感染与恶性淋巴增生性疾病之间可能存在的关联。对新诊断的 LPD 患者进行血浆和 PBMC 中 HCV-RNA 的检测。还通过透射和免疫电子显微镜检查了受试者的 PBMC。LPD 患者显示出高比例的 HCV 感染(71.9%):OCI-HCV(37.5%)和 HCV(34.38%)。同时,28.13%的 LPD 患者没有任何 HCV 感染的证据。PBMC 的超微结构检查显示存在包含类似病毒颗粒的胞质空泡,在隐匿性 HCV 患者中这些空泡不太明显。在 LPD 患者中应考虑隐匿性 HCV 的可能性,这有助于管理治疗方案,以在控制肿瘤进展和最小化与 HCV 感染相关的化疗后并发症之间取得平衡。